Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021

Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating strain in the United States are limited (1-3). CDC used the VISION Network* to examine medical encounters (32,867) from 187 hospitals and...

Full description

Saved in:
Bibliographic Details
Published inMMWR. Morbidity and mortality weekly report Vol. 70; no. 37; pp. 1291 - 1293
Main Authors Grannis, Shaun J, Rowley, Elizabeth A, Ong, Toan C, Stenehjem, Edward, Klein, Nicola P, DeSilva, Malini B, Naleway, Allison L, Natarajan, Karthik, Thompson, Mark G
Format Journal Article Newsletter
LanguageEnglish
Published United States U.S. Government Printing Office 17.09.2021
U.S. Center for Disease Control
Centers for Disease Control and Prevention
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating strain in the United States are limited (1-3). CDC used the VISION Network* to examine medical encounters (32,867) from 187 hospitals and 221 emergency departments (EDs) and urgent care (UC) clinics across nine states during June-August 2021, beginning on the date the Delta variant accounted for >50% of sequenced isolates in each medical facility's state. VISION Network methods have been published (4).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0149-2195
1545-861X
DOI:10.15585/MMWR.MM7037E2